ATFS, POLYAMIDE SYNTHESIS
ATFS, POLYAMIDE SYNTHESIS
批准号:
7954647
负责人:
ASEEM Z ANSARI
金额:
$0.01万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-01 至 2010-02-28
关键词:
Biochemical PathwayCellsComplementComputer Retrieval of Information on Scientific Projects DatabaseDataEngineeringFundingGenesGeneticGenetic TranscriptionGoalsGrantHigh Pressure Liquid ChromatographyInstitutionMethodsNylonsPropertyProteinsRegulator GenesResearchResearch PersonnelResolutionResourcesSmall Interfering RNASourceTherapeutic AgentsUnited States National Institutes of HealthValidationfunctional genomicsmagnetic fieldsynthetic biologytooltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The major goals of our lab are to understand mechanisms that govern gene regulatory networks and to create synthetic molecules such as artificial transcription factors (ATFs) that can be engineered to control these networks in a predetermined manner. ATFs, due to their ability to stimulate transcription, will complement the siRNA approach and serve as powerful, functional, genomics tools that identify and control the gene networks which govern cell fate. They will also contribute to the nascent field of synthetic biology and metabolic network engineering by proving to be a versatile tool in the regulatation of submodules of gene networks. As the ultimate value of ATFs lies in their potential application as precision-tailored therapeutic agents, we aim to regulate transcriptional circuitry by creating synthetic molecules that mimic the properties of natural transcription factors or counteract the activity of malfunctioning genetic machinery. It is therefore of the utmost importance that the identities of the molecules (i.e., synthetic mimics) we synthesize are confirmed via thorough structural analyses before proceeding further. We wish to incorporate NMR data as the primary method of structural validation, corroborated by mass spec and HPLC data. Although this particular project probably requires only low field NMR analysis (400 MHz), we are currently planning other projects which would require resolution of more complicated proteins therefore necessitating the use of much higher magnetic fields.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
-
批准号:10382433
-
项目类别:
-
资助金额:$60.85万
-
财政年份:2018
-
负责人:ASEEM Z ANSARI
-
依托单位:
Synthetic molecules to stimulate the expression of Frataxin to ameliorate Freidreichs Ataxin
-
批准号:10078821
-
项目类别:
-
资助金额:$42.6万
-
财政年份:2018
-
负责人:ASEEM Z ANSARI
-
依托单位:
Revealing Masked Specificities of Human Nuclear Receptors
-
批准号:10078820
-
项目类别:
-
资助金额:$54.74万
-
财政年份:2016
-
负责人:ASEEM Z ANSARI
-
依托单位:
Revealing masked specificities of human Nuclear Receptors
-
批准号:9356561
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2016
-
负责人:ASEEM Z ANSARI
-
依托单位:
STRUCTURE AND DNA BINDING STUDIES OF NANOG, SOX2, AND OCT4
-
批准号:8361239
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2011
-
负责人:ASEEM Z ANSARI
-
依托单位:
Modular design of synthetic transcriptional regulators
-
批准号:8031050
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2010
-
负责人:ASEEM Z ANSARI
-
依托单位:
GAL4/MED15 BINDING AND CONFORMATION STUDY
-
批准号:8168964
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2010
-
负责人:ASEEM Z ANSARI
-
依托单位:
ATFS, POLYAMIDE SYNTHESIS
-
批准号:8168955
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2010
-
负责人:ASEEM Z ANSARI
-
依托单位:
GAL4/MED15 BINDING AND CONFORMATION STUDY
-
批准号:7954668
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2009
-
负责人:ASEEM Z ANSARI
-
依托单位:
SYNTHESIS OF PNA-ENCODED COMBINATORIAL PEPTIDE LIBRARIES
-
批准号:7954648
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:ASEEM Z ANSARI
-
依托单位:
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules
-
批准号:8080440
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2008
-
负责人:ASEEM Z ANSARI
-
依托单位:
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules
-
批准号:7848104
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2008
-
负责人:ASEEM Z ANSARI
-
依托单位:
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules
-
批准号:8265652
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2008
-
负责人:ASEEM Z ANSARI
-
依托单位:
Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules
-
批准号:7638568
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2008
-
负责人:ASEEM Z ANSARI
-
依托单位:
Modular design of synthetic transcriptional regulators
-
批准号:7030370
-
项目类别:
-
资助金额:$25.26万
-
财政年份:2006
-
负责人:ASEEM Z ANSARI
-
依托单位:
Modular design of synthetic transcriptional regulators
-
批准号:7327765
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2006
-
负责人:ASEEM Z ANSARI
-
依托单位:
Modular design of synthetic transcriptional regulators
-
批准号:7161469
-
项目类别:
-
资助金额:$24.51万
-
财政年份:2006
-
负责人:ASEEM Z ANSARI
-
依托单位:
Modular design of synthetic transcriptional regulators
-
批准号:7569395
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2006
-
负责人:ASEEM Z ANSARI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: